Indoco Remedies Approves Allotment of 14,850 Equity Shares Under ESOP Plan
Indoco Remedies Ltd · Others (Uncategorized) · 27 Oct 2026, 3:31 pm
Indoco Remedies Approves Allotment of 14,850 Equity Shares Under ESOP Plan The Nomination and Remuneration Committee of Indoco Remedies approved the allotment of 14,850 equity shares (face value Rs. 2 each) to the Indoco Employees Welfare Trust under its Employee Stock Option Plan–2022 on 27th Oct'26. The shares were issued at an exercise price of Rs. 2 each, totaling Rs. 29,700. Consequently, the company's paid-up equity share capital increased from Rs. 18,46,07,210 (9,23,03,605 shares) to Rs. 18,46,36,910 (9,23,18,455 shares).
Original exchange filing (PDF)
More announcements from Indoco Remedies Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare & Aruna Kare · 18 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others · 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare · 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare · 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others · 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ms. Aditi M Panandikar & Ms. Madhura Suresh Kare · 04 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others · 03 Nov 2026
- Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2026 · 29 Oct 2026
